GO
Loading...

Why Gilead isn't soaring

Wednesday, 23 Jul 2014 | 5:12 PM ET

Gilead Sciences reported Q2 EPS of $2.36 ex-items on revenue of $6.53 billion, with $3.48 billion sales of Sovaldi. CNBC's Meg Tirrell reports the highlights from the conference call.